Tata Memorial study finds Nimotuzumab increases survival in head and neck cancer
Patients with head and neck cancer who received Nimotuzumab in combination with concurrent radiotherapy and cisplatin had a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.